Ozone therapy as a tool for HPV related cancers
Ozone therapy is emerging as a promising ally in the fight against HPV‑related cervical disease, with early clinical and translational research suggesting it may help reduce viral persistence, support local immunity, and potentially lower the risk of progression to cervical cancer when used as part of a comprehensive care plan.
How ozone therapy works in HPV
Ozone therapy delivers a carefully controlled gas mixture, most often via intravaginal insufflation, directly to the lower gynecological tract (vagina, exocervix, endocervix). This route allows broad contact with the surfaces where HPV tends to persist and where pre-cancerous changes arise. Preclinical and biochemical work suggests ozone can disrupt viral particles, modulate oxidative balance, and influence signaling pathways involved in chronic inflammation and cancer progression. By improving local conditions and immune activity, ozone may help the cervix clear high‑risk HPV before it progresses to lesions or invasive cancer.
Emerging clinical benefits in HPV and cervical lesions
Several clinical reports and small studies describe encouraging outcomes when ozone is added to the management of HPV infections of the cervix. A prospective uncontrolled study of women with cervical HPV lesions found that intravaginal ozone, given over roughly six weeks, was associated with favorable cell changes, suggesting regression or improvement of HPV‑related abnormalities. Another clinical series comparing integrative care plus ozone versus ozone alone reported HPV clearance in about 80% of women receiving combined ozone–integrative therapy and about 60% in those treated with ozone alone, indicating that ozone can meaningfully contribute to viral control, especially within a multimodal protocol.
A preventive strategy against HPV‑related cervical cancer
A 2025 literature review specifically examined ozone vaginal insufflation as a strategy to prevent HPV‑related cancers of the lower gynecological tract. The authors highlight that ozone gas can diffuse simultaneously through the exocervix, endocervix, and upper vagina, covering the entire “at‑risk” mucosal field rather than just a small treated spot. This field‑effect is important because HPV‑driven changes can arise at multiple sites, and a therapy that addresses the whole transformation zone may help reduce the chance that hidden foci are left behind. The review concludes that ozone therapy appears to be a particularly interesting preventive tool for HPV‑positive women when integrated with standard surveillance, vaccination where applicable, and individual risk‑factor modification.
Synergy with the vaginal microbiome and oxidative balance
Modern research emphasizes that HPV persistence and progression to CIN and cervical cancer are not driven by the virus alone; they are strongly influenced by the vaginal microenvironment and chronic oxidative stress. Disturbed vaginal microbiota, elevated pH, and ongoing reactive oxygen species (ROS) production all contribute to DNA damage and immune dysregulation in the cervix. By modulating oxidative balance and exerting antimicrobial effects, ozone therapy may help restore a healthier vaginal ecosystem that is less hospitable to HPV infection. This ecological perspective makes ozone not just an antiviral tool, but a broader regulator of the cervical environment that supports mucosal healing and resilience.
References:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11817107/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10590607/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6151231/
https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.e17515
https://www.sciencedirect.com/science/article/abs/pii/S0753332218328385
https://pmc.ncbi.nlm.nih.gov/articles/PMC12653057/
https://www.sciencedirect.com/science/article/abs/pii/S0753332218333092
Dr. Jennifer Kerr, ND
